John A. Johnson, MD, MBA: The microvascular complications of diabetes include anything from effects on [a patient’s] blood pressure, peripheral neuropathy, the ability to have abnormalities in their sensation (in their hands and feet), and blindness. Macrovascular complications include cardiovascular effects such as heart attacks, stroke, and end-stage kidney disease.
So we look at ways that we can, in a preventative approach, reduce those complications because, as we’ve seen at WellCare, in patients who don’t have access to care—either inadequate access or lack of behavioral modification in lifestyle changes—a negative impact in their outcomes is seen.
We work with the provider community to make them aware of the members that they have within their care—that are WellCare members—and [figure out] how we can partner with them and equip them with tools to enhance the care of diabetics to prevent or delay the onset of these micro- and macrovascular complications.
Health Equity Conversations: Managing Underserved Communities and Value-Based PaymentMay 23rd 2023
On this episode of Managed Care Cast, we feature several leaders in diversity, equity, and inclusion advancing health equity in their respective organization’s policy and practice initiatives.
Combo Therapy Relieves Delayed Rash Symptoms in AD Following mRNA VaccineMay 25th 2023
In a case report, dupilumab and prednisone were among the treatments for atopic dermatitis (AD) used to relieve a patient of her delayed generalized hypersensitivity reaction to the mRNA COVID-19 vaccine.
2 Clarke Drive
Cranbury, NJ 08512